RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ONIDA F
Collezione AOU Alessandria

Items : 4

Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC). in Bone marrow transplantation / Bone Marrow Transplant. 2024 Aug;59(8):1084-1091. doi: 10.1038/s41409-024-02282-7. Epub 2024 Apr 25.

2024
AOU Alessandria

Niederwieser C; Iacobelli S; Franke GN; Koster L; van Os M; Platzbecker U; Hübel K; Scheid C; Müller LP; Stelljes M; Morozova E; Passweg J; Onida F; Dreger P; Saccardi R; Ladetto M; Salmenniemi U; Bethge W; Poiré X; Kobbe G; McLornan DP; Robin M; Kröger N;

Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Jun;57(6):949-958. doi: 10.1038/s41409-022-01626-5. Epub 2022 Apr 12.

2022
AOU Alessandria
AOU Città della Salute di Torino

Oldani E; Vallisa D; Sacchi N; Vacca A; Tringali S; Parma M; Palazzo G; Onida F; Musso M; Grillo G; Casini M; Baronciani D; Nozzoli C; Cupri A; Luppi M; Chiusolo P; Carluccio P; Sorasio R; Santarone S; Proia A; Picardi A; Cilloni D; Carella AM; Di Grazia C; Brunello L; Patriarca F; Iori AP; Grassi A; Busca A; et alii...

Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantation. in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2020 Oct;26(10):e256-e262. doi: 10.1016/j.bbmt.2020.06.032. Epub 2020

2020
AOU Alessandria
AOU Città della Salute di Torino

Ferrario A; Reda G; Zallio F; Vallisa D; Magagnoli M; Onida F; Fanin R; Quaresmini G; Salvetti C; Coscia M; Frustaci AM; Patriarca F; Bruno B; Barretta F; Scarfò L; Farina L; Corradini P; Montillo M; Farina L; Barretta F; Scarfò L; Bruno B; Patriarca F; Frustaci AM; Coscia M; Salvetti C; Quaresmini G; Fanin R; Onida F; et alii...

Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-Begelomab. in Bone marrow transplantation / Bone Marrow Transplant. 2020 Aug;55(8):1580-1587. doi: 10.1038/s41409-020-0855-z. Epub 2020 Mar 13.

2020
AOU Alessandria

Bacigalupo A; Angelucci E; Raiola AM; Varaldo R; Di Grazia C; Gualandi F; Benedetti E; Risitano A; Musso M; Zallio F; Ciceri F; Chiusolo P; Sica S; Rambaldi A; Bonifazi F; Parma M; Martino M; Onida F; Iori AP; Selleri C; Borghero C; Bertaina A; Prezioso L; Algeri M; Locatelli F;